Company: ABBV
Filing Date: 2025-03-10
Form Type: PRE 14A
Source: 0001558370-25-002603
Chunk: 94

Company: AbbVie Inc.
Filing Date: 2025-03-10
Form: PRE 14A
Chunk 94
---
 respect and dignity; protecting employees’ personal information; encouraging open communication between managers and employees; and complying with laws and practices that prohibit child labor, forced, bonded or indentured labor, involuntary prison labor, human trafficking and unfair wages and benefits. Employees can anonymously voice their concerns through a variety of mechanisms including our global hotline. In acknowledgment of AbbVie’s efforts, we are consistently recognized for this workplace culture and treatment of our employees. AbbVie has scored 100% for eight consecutive years on the Human Rights Campaign Corporate Equality Index and is consistently ranked highly by Disability:IN as a best place to work for disability inclusion, Fortune 100 Best Companies to Work For ®, Great Place to Work’s World’s Best Workplaces TM, and as a Seramount 100 Best Companies. In addition to our suppliers and own workforce, AbbVie understands the impact it has on the health of patients. We recognize that innovative treatments can make a difference only if patients can get the medicines that they and their providers choose. We price our medicines to reflect the value they bring to patients and their families, the health system, and to society. We also consider the affordability and accessibility of our medicines for a diverse set of stakeholders, including patients, providers, governments and other payers, as well as the long-term sustainability of our innovation and societal impact. 2025 Proxy Statement |81

| ​                     | ​ |
| STOCKHOLDER PROPOSALS | ​ |

We actively work to broaden access and increase affordability for patients in a variety of circumstances. While making our treatments available in approximately 175 countries, we offer several programs that reduce out-of-pocket costs for patients. Through medicine donation programs, we provide medicines for people who have no other means of accessing them including seven ongoing medicine donation partnerships with non-governmental organizations providing care in low-and-middle income countries. We also support requests for donations for pediatric health, mental health and HIV/AIDS treatments, and access to surgical care by donating our general anesthesia treatment for use in free surgeries. Other examples of how we make our products available to those in need can be found in our Pricing and Access of Our Innovative Medicinesreport on our website. The Board of Directors recommends that you vote AGAINST the proposal. 82 | 2025 Proxy Statement

ADDITIONAL INFORMATION Corporate Governance Materials AbbVie’s corporate governance guidelines with the outline of directorship qualifications; director independence guidelines; code of business conduct; and audit committee, compensation committee, nominations and governance committee, and public policy and sustainability committee charters are